Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls

Journal of Diabetes

Volumn 7, Issue 6, 2015, Pages 779-790

  Ofstad, Anne Pernille ^a   Urheim, Stig ^e   Dalen, Håvard ^b,c   Orvik, Elsa ^a   Birkeland, Kåre I ^d,f   Gullestad, Lars ^e,f   W Fagerland, Morten ^g   Johansen, Odd Erik ^a   Aakhus, Svend ^b,e  

^a VESTRE VIKEN HOSPITAL TRUST   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Levanger Hospital   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Diabetic cardiomyopathy; Echocardiography; Left ventricular dysfunction; Obesity; Type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR PARAMETERS; CLINICAL FEATURE; COHORT ANALYSIS; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECELERATION; DIABETIC CARDIOMYOPATHY; DIABETIC PATIENT; DIASTOLE; DIASTOLIC DYSFUNCTION; DYSLIPIDEMIA; EARLY TRANSMITRAL FILLING; ECHOCARDIOGRAPH; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL TISSUE VELOCITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; CASE CONTROL STUDY; COLOR DOPPLER ECHOCARDIOGRAPHY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; ECHOGRAPHY; EPIDEMIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; STATISTICAL MODEL; SYSTOLE;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 84945490841     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12239     Document Type: Article

References (31)

1. Grundy SM, Benjamin IJ, Burke GL etal. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation. 1999; 100: 1134-1146.
2. Devereux RB, Roman MJ, Paranicas M etal. Impact of diabetes on cardiac structure and function: The strong heart study. Circulation. 2000; 101: 2271-2276.
3. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol. 1974; 34: 29-34.
4. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007; 115: 3213-3223.
5. Stefanidis A, Bousboulas S, Kalafatis J etal. Left ventricular anatomical and functional changes with ageing in type 2 diabetic adults. Eur J Echocardiogr. 2009; 10: 647-653.
6. Boonman-de Winter LJ, Rutten FH, Cramer MJ etal. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012; 55: 2154-2162.
7. From AM, Scott CG, Chen HH. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol. 2010; 55: 300-305.
8. Ernande L, Bergerot C, Rietzschel ER etal. Diastolic dysfunction in patients with type 2 diabetes mellitus: Is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr. 2011; 24: 1268-1275 e1.
9. Vinereanu D, Nicolaides E, Tweddel AC etal. Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond). 2003; 105: 591-599.
10. Dodiyi-Manuel ST, Akpa MR, Odia OJ. Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria. Vasc Health Risk Manag. 2013; 9: 529-533.
11. Cosson S, Kevorkian JP, Virally ML etal. No evidence for left ventricular diastolic dysfunction in asymptomatic normotensive type 2 diabetic patients: A case-control study with new echocardiographic techniques. Diabetes Metab. 2007; 33: 61-67.
12. Ichikawa R, Daimon M, Miyazaki T etal. Influencing factors on cardiac structure and function beyond glycemic control in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2013; 12: 38.
13. Johansen OE, Birkeland KI, Orvik E etal. Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects. Scand J Clin Lab Invest. 2007; 67: 306-316.
14. Holmen J, Midthjell K, Krüger Ø etal. The Nord Trøndelag Health study 1995-97 (HUNT2): Objectives, contents, methods and participation. Norsk Epidemiologi. 2003; 13: 19-32.
15. Dalen H, Thorstensen A, Aase SA etal. Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: The HUNT study in Norway. Eur J Echocardiogr. 2010; 11: 176-183.
16. Gottdiener JS, Bednarz J, Devereux R etal. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004; 17: 1086-1119.
17. Lang RM, Bierig M, Devereux RB etal. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-1463.
18. Nagueh SF, Appleton CP, Gillebert TC etal. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22: 107-133.
19. Nikitin NP, Witte KK, Thackray SD etal. Longitudinal ventricular function: Normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr. 2003; 16: 906-921.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1: 307-310.
21. Sun JP, Popovic ZB, Greenberg NL etal. Noninvasive quantification of regional myocardial function using Doppler-derived velocity, displacement, strain rate, and strain in healthy volunteers: Effects of aging. J Am Soc Echocardiogr. 2004; 17: 132-138.
22. van Heerebeek L, Hamdani N, Handoko ML etal. Diastolic stiffness of the failing diabetic heart: Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008; 117: 43-51.
23. Poirier P, Bogaty P, Garneau C etal. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001; 24: 5-10.
24. Fang ZY, Schull-Meade R, Downey M etal. Determinants of subclinical diabetic heart disease. Diabetologia. 2005; 48: 394-402.
25. Faden G, Faganello G, De Feo S etal. The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: Data from the SHORTWAVE study. Diabetes Res Clin Pract. 2013; Sep;101(3): 309-316. doi: 10.1016/j.diabres.2013.07.004.
26. Boyer JK, Thanigaraj S, Schechtman KB etal. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004; 93: 870-875.
27. Berkalp B, Cesur V, Corapcioglu D etal. Obesity and left ventricular diastolic dysfunction. Int J Cardiol. 1995; 52: 23-26.
28. Frohlich ED, Apstein C, Chobanian AV etal. The heart in hypertension. N Engl J Med. 1992; 327: 998-1008.
29. Hansen A, Johansson BL, Wahren J etal. C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes. 2002; 51: 3077-3082.
30. Mogelvang R, Sogaard P, Pedersen SA etal. Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: The Copenhagen City Heart Study. Eur Heart J. 2009; 30: 731-739.
31. Dalen H, Thorstensen A, Romundstad PR etal. Cardiovascular risk factors and systolic and diastolic cardiac function: A tissue Doppler and speckle tracking echocardiographic study. J Am Soc Echocardiogr. 2011; 24: 322-332 e6.